Cadherin‐3 is a novel oncogenic biomarker with prognostic value in glioblastoma

Glioblastoma (GBM) is the most common and malignant primary brain tumor in adults. The prognosis of patients is very poor, with a median overall survival of ~ 15 months after diagnosis. Cadherin‐3 (also known as P‐cadherin), a cell–cell adhesion molecule encoded by the CDH3 gene, is deregulated in s...

Descripción completa

Detalles Bibliográficos
Autores principales: Martins, Eduarda P., Gonçalves, Céline S., Pojo, Marta, Carvalho, Rita, Ribeiro, Ana S., Miranda‐Gonçalves, Vera, Taipa, Ricardo, Pardal, Fernando, Pinto, Afonso A., Custódia, Carlos, Faria, Cláudia C., Baltazar, Fátima, Sousa, Nuno, Paredes, Joana, Costa, Bruno M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297769/
https://www.ncbi.nlm.nih.gov/pubmed/34919784
http://dx.doi.org/10.1002/1878-0261.13162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297769/
https://www.ncbi.nlm.nih.gov/pubmed/34919784
http://dx.doi.org/10.1002/1878-0261.13162

Ejemplares similares